$Regencell Bioscience(RGC.US) pulled up again, rising nine points, with trading volume several times higher than usual—this is a small-cap stock focused solely on traditional Chinese medicine for ADHD and autism, and it has actually been in a deep decline throughout the year. This move looks more like short covering plus speculative capital entering, with no new clinical or commercialization news released.

For a short squeeze like this, the hard part to judge is the timing: is the short squeeze just starting, or is it another one-day wonder? It seems more like the latter; a squeeze without fundamental support usually can't last more than a few trading days🤔